108 related articles for article (PubMed ID: 10925120)
1. Analysis of the mechanism of discrepant nuclear morphometric results comparing preoperative biopsy and prostatectomy specimens.
Kanamaru H; Zhang YH; Takahashi M; Nakamura N; Ishida H; Akino H; Muranaka K; Okada K
Urology; 2000 Aug; 56(2):342-5. PubMed ID: 10925120
[TBL] [Abstract][Full Text] [Related]
2. Comparison of nuclear morphometric results between needle biopsy and surgical specimens from patients with prostate cancer.
Zhang YH; Kanamaru H; Oyama N; Miwa Y; Suzuki Y; Akino H; Noriki S; Okada K
Urology; 1999 Oct; 54(4):763-6. PubMed ID: 10510944
[TBL] [Abstract][Full Text] [Related]
3. Histology of specimens taken by prostatectomy and needle biopsy.
Ngugi PM; Byakika B
East Afr Med J; 2007 Aug; 84(8):363-6. PubMed ID: 17970003
[TBL] [Abstract][Full Text] [Related]
4. Morphometric quantitation of stroma in human benign prostatic hyperplasia.
Deering RE; Bigler SA; King J; Choongkittaworn M; Aramburu E; Brawer MK
Urology; 1994 Jul; 44(1):64-70. PubMed ID: 7518983
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of nuclear morphometry on needle biopsy from patients with prostate cancer: is volume-weighted mean nuclear volume superior to other morphometric parameters?
Zhang YH; Kanamaru H; Oyama N; Miwa Y; Suzuki Y; Akino H; Noriki S; Okada K
Urology; 2000 Mar; 55(3):377-81. PubMed ID: 10699614
[TBL] [Abstract][Full Text] [Related]
6. Nuclear morphometry in automatic biopsy and radical prostatectomy specimens of prostatic carcinoma. A comparison.
Mohler JL; Metts JC; Zhang XZ; Maygarden SJ
Anal Quant Cytol Histol; 1994 Dec; 16(6):415-20. PubMed ID: 7710616
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
[TBL] [Abstract][Full Text] [Related]
8. Nuclear morphometry in histological specimens of canine prostate cancer: Correlation with histological subtypes, Gleason score, methods of collection and survival time.
Di Donato G; Laufer-Amorim R; Palmieri C
Res Vet Sci; 2017 Oct; 114():212-217. PubMed ID: 28502900
[TBL] [Abstract][Full Text] [Related]
9. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
[TBL] [Abstract][Full Text] [Related]
10. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
11. Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia.
McNeal J; Noldus J
Urology; 1996 Nov; 48(5):751-6. PubMed ID: 8911519
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral heterogeneity in prostate cancer demonstrated by volume-weighted mean nuclear volume.
Fujikawa K; Sasaki M; Aoyama T; Itoh T; Yoshida O
APMIS; 1997 Apr; 105(4):322-8. PubMed ID: 9164477
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of cyclooxygenase-2 over expression for identifying prostate cancer from benign prostatic hyperplasia in prostate biopsy specimens.
Ceylan Y; Lekili M; Muezzinoglu T; Nese N; Isisag A
Minerva Urol Nefrol; 2016 Jun; 68(3):255-62. PubMed ID: 26125280
[TBL] [Abstract][Full Text] [Related]
14. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.
Marks LS; Treiger B; Dorey FJ; Fu YS; deKernion JB
Urology; 1994 Oct; 44(4):486-92. PubMed ID: 7524234
[TBL] [Abstract][Full Text] [Related]
15. Cytological atypia in the prostate gland: frequency, distribution and possible relevance to carcinoma.
Oyasu R; Bahnson RR; Nowels K; Garnett JE
J Urol; 1986 May; 135(5):959-62. PubMed ID: 2421020
[TBL] [Abstract][Full Text] [Related]
16. Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?
Viglione MP; Potter S; Partin AW; Lesniak MS; Epstein JI
Hum Pathol; 2002 Aug; 33(8):796-800. PubMed ID: 12203211
[TBL] [Abstract][Full Text] [Related]
17. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study.
Yang XJ; Lecksell K; Short K; Gottesman J; Peterson L; Bannow J; Schellhammer PF; Fitch WP; Hodge GB; Parra R; Rouse S; Waldstreicher J; Epstein JI
Urology; 1999 Apr; 53(4):696-700. PubMed ID: 10197843
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer.
Hsieh TF; Chang CH; Chen WC; Chou CL; Chen CC; Wu HC
J Chin Med Assoc; 2005 Apr; 68(4):167-71. PubMed ID: 15850066
[TBL] [Abstract][Full Text] [Related]
19. Obtaining fresh prostate cancer tissue for research: a novel biopsy needle and sampling technique for radical prostatectomy specimens.
Walton TJ; McCulloch TA; Rees RC; Bishop MC
Prostate; 2005 Sep; 64(4):382-6. PubMed ID: 15754345
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
